Cargando…
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous human suffering. To date, no effective drug is available to directly treat the disease. In a search for a drug against COVID-19, we have performed a high-throughput x-ray crystallographic screen of two repurposing drug li...
Ejemplares similares
-
Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease
por: Srinivasan, Vasundara, et al.
Publicado: (2022) -
Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease
por: Ewert, Wiebke, et al.
Publicado: (2022) -
Opening opportunities for K(d) determination and screening of MHC peptide complexes
por: Kopicki, Janine-Denise, et al.
Publicado: (2022) -
P13, the EMBL macromolecular crystallography beamline at the low-emittance PETRA III ring for high- and low-energy phasing with variable beam focusing
por: Cianci, Michele, et al.
Publicado: (2017) -
What happened to financially sustainable firms in the Corona crisis?
por: Günther, Thomas, et al.
Publicado: (2020)